Access cutting-edge prostate cancer treatment through this clinical trial at a research site in Little Rock. Study-provided care at no cost to qualified participants.
Access prostate cancer specialists in Little Rock at no cost
This study follows strict safety protocols and ethical guidelines
All study-related prostate cancer treatment provided free
This phase III trial uses the Decipher risk score to guide therapy selection. Decipher score is based on the activity of 22 genes in prostate tumor and may predict how likely it is for recurrent prostate cancer to spread (metastasize) to other parts of the body. Decipher score in this study is used for patient selection and the two variations of treatment to be studied: intensification for higher Decipher score or de-intensification for low Decipher score. Patients with higher Decipher risk scor
Sponsor: NRG Oncology
Check if you qualify for this prostate cancer clinical trial in Little Rock, AR
If you're searching for prostate cancer treatment options in Little Rock, AR, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Little Rock research site is actively enrolling participants for this clinical trial. You'll receive care from experienced prostate cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.